From the 10 to the 15 of January 2022 in our Sala Goldoni.
“LEVI CAMPUS” 10 – 15 January 2022
REGULATION, LEGISLATION & SAFETY OF BIOSTIMULANTS AND BIOFERTILISERS INCLUDING NANOFORMULATES 30TH SEPT. 2ND OCTOBER 2021
From 30th September to 2nd October 2021 we hosted SIMBA School in our Sala Vivaldi, which is organized by CINSA (Consorzio Interuniversitario Nazionale per le Scienze Ambientali). During the School many projects and reviews about microbial technologies and nanotechnologies. Risk assessment ansd safety aspects in the application of nano-technologies to agricolture and food production.
For further information please contact: Prof. Elena Maestri – Università di Parma
cinsa@unipr.it or www.simbaproject.eu
EUROACADEMIA – 8th Global Forum of Critical Studies 24th-25th JANUARY 2020
The 8th Euroacademia Global Forum of Critical Studies aims to bring into an open floor the reflexive and questioning interaction among academics, intellectuals, practitioners, performers, artists and activists profoundly concerned with evaluative understandings of the world we’re all living in. The focus of the forum is to initiate an arena where no question is misplaced and irrelevant as long as we acknowledge that evaluation, critical thinking and contestation are accessible trajectories to better understanding our past, present and alternative scenarios for the future. The Forum is also an open stage for sharing existing or ready formed intellectual visions and expose them to dialogue and scrutiny in a critically reflective environment. The 8th edition of the forum aims to become a creative meeting point for all the critical studies perspectives coming from intellectuals, academics, performing artists, change makers and idea shapers.
For information: www.euroacademia.eu
VENETIA TRIOMPHANTE – ARTISTIC AND HISTORICAL ITINERARIES OCT.-NOV. 2019
EBT ENTE BILATERALE TERRITORIALE UNITARIO SETTORE TURISMO DELLA PROVINCIA DI VENEZIA, organized in our Sala Canova a course of art and history about Venice.
For information, please contact:
EBT ENTE BILATERALE TURISMO PROVINCIA DI VENEZIA
Mrs. Chiara Pesce
Tel. 0039 041 5093133
NEXT – DIABETES 2 – SALA GOLDONI 11th and 12th OCTOBER 2019
Cardiovascular diseases are the leading cause of death for patients with diabetes: among these patients, in fact, the main cardiovascular risk factors are more frequent and result in more serious consequences than the general population.
In the treatment of type 2 diabetes, optimal management of glycemic values is the first level of therapy and represents the foundation of the profession of diabetologist. However, nowadays it appears more and more evident and important for the doctor to evaluate the high impact that cardiovascular diseases have on diabetes and on the management of this disease and consequently, consider this fundamental aspect in choosing the best drug therapy for the diabetic patient.
The new therapeutic options for type 2 diabetes are presented to the diabetologist as innovative solutions able to offer beyond the glycemic control, a proven protection from cardiovascular risk.
Recent studies have evaluated and demonstrated the effects of long-term treatment of some of these drugs on cardiovascular morbidity and mortality.
The most recent Italian guidelines (Italian standards for the treatment of diabetes mellitus 2018) have accepted the new scientific evidence and proposed a new algorithm for the treatment of type 2 diabetes that includes the most important classes of innovative drugs with particular attention to those with proven effectiveness in terms of cardiovascular protection.
A training course was held in our Goldoni Room on 11 and 12 October, which will allow participants to deepen the link between type 2 diabetes and cardiovascular risk, implementing knowledge of the new classes of drugs and their use in patient care diabetic.
The initiative is an interactive training project, of national importance, whose goal is to give the diabetologist the new evidence on type 2 diabetes and cardiovascular protection, with particular regard to the class of SGLT2 inhibitors.
For more information, contact:
ABOUT EVENTS SRL
Tel. 0039 02 89634651